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ABSTRACT
Aim: To evaluate a new approach of recanalisation of
nasolacrimal duct obstruction (RC-NLDO) in the treatment
of the nasolacrimal duct obstruction (NLDO) and chronic
dacryocystitis.
Methods: 583 patients with 641 eyes suffering from
NLDO and chronic dacryocystitis were enrolled in this
study. The RC-NLDO was performed in 506 eyes, with
135 eyes undergoing external dacryocystorhinostomy (EX-
DCR) as controls. Patient follow-up for 54 months was
evaluated by symptoms, dye disappearance test, lacrimal
irrigation and digital subtraction dacryocystogram. The
RC-NLDO was also performed in 12 rhesus monkeys for
histopathological examination.
Results: The clinical success rates were 93.1% in 506
cases of RC-NLDO and 91.11% in 135 cases of EX-DCR.
The success rates for second surgery were achieved in
85.19% on RC-NLDO and 40.0% on EX-DCR. No major
intra- or postoperative complications were observed in the
RC-NLDO group. The mean operative duration was
12.5 min for RC-NLDO and 40.3 min for EX-DCR
(p,0.001). A pathological study in rhesus monkeys
demonstrated that the RC-NLDO wounded epithelium in
nasolacrimal duct healed completely within 1 month
without granulation tissue formation.
Conclusion: The findings demonstrate that the RC-NLDO
is a simple and effective approach proven to recanalise
the obstructed nasolacrimal duct with a comparable
success rate to EX-DCR.
Nasolacrimal duct obstruction (NLDO) and
chronic dacryocystitis are common ophthalmic
diseases. The external dacryocystorhinostomy
(EX-DCR) has been the most effective and
standard surgery in treating these conditions since
1904 when it was reported by Toti.
1 However, EX-
DCR is an invasive, relatively complex and time-
consuming procedure that causes a facial cuta-
neous scar. Many patients prefer to suffer tearing
rather than undergo this surgery.
23The improve-
ment on DCR has been made recently, such as the
endonasal DCR and endocanalicular laser DCR.
These approaches were promising but still necessi-
tate bone removal and require costly equipment.
These surgical procedures were reported to have
less effective results than EX-DCR and involve a
marked learning curve.
4–9 The approach of the EX-
DCR and these new procedures is to create a
bypass draining system, rather than to restore the
obstructed nasolacrimal duct.
Recanalisation of nasolacrimal duct obstruction
(RC-NLDO) was an evolutionally developed surgi-
cal approach for treating these conditions to
restore the native nasolacrimal duct, using a simple
instrument, the lacrimal canaliser, which we
created in 1994.
10 Since then, this approach has
been widely adopted by many ophthalmologists in
China for its simplicity, safety, efficacy and
minimal invasion.
11–15 In the present study, we
report the long-term follow-up results of RC-
NLDO in the clinical treatment for 506 cases of
NLDO and chronic dacryocystitis, as well as the
histopathological evidence from animal experi-
ments. The relative indication, contraindication,
surgical technique, postoperative care, complica-
tions, advantages and disadvantages of the RC-
NLDO are discussed.
MATERIALS AND METHODS
Patients
This study adhered to the tenets of the Declaration
of Helsinki and was approved by the Institutional
Review Board (IRB)/Ethics Committee of
Zhongshan Ophthalmic Center, Sun Yat-sen
University. All cases were chosen from outpatients
who were diagnosed as having NLDO and/or
chronic dacryocystitis. Every patient underwent
preoperatively comprehensive ophthalmic and
intranasal examination. Dacryocystogram or digi-
tal subtraction dacryocystogram was performed in
some cases.
A total of 641 eyes of 583 consecutive patients
were recruited from July 2003 to June 2006 with
their signed informed consent forms, including 135
eyes of 126 patients undergoing the EX-DCR and
506 eyes of 457 patients undergoing the RC-
NLDO. There were no statistical differences in
patient demographics between these two groups.
The male-to-female ratio was approximately 1:3,
and the average age was 50 years. The duration of
symptoms ranged from 6 months to 26 years
(mean 5.1 years) in the RC-NLDO group and from
6 months to 17 years (mean 4.7 years) in the EX-
DCR group.
Instrument used for RC-NLDO
The instrument used for recanalisation of nasola-
crimal duct obstruction was the lacrimal canaliser
consisting of a console and its accessories (fig 1).
The console can discharge a power current (50–
150 W) with 500 kHz frequency. The high-fre-
quent lacrimal (HFL) probe is made of copper–
silver alloy 1.2 mm in diameter and 140 mm in
length. Its tip is 2.0 mm long, smooth, blunt and
naked (without an insulating coat on the surface),
features allowing it to cauterise blocked tissue in a
nasolacrimal duct.
Surgical procedures
EX-DCR was performed under local anaesthesia in
a standardised fashion.
9 The RC-NLDO was
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hydrochloride. The inferior nasal meatus was treated twice with
a pledget soaked in 0.5% Alcaine eye-drops (Alcon, Fort Worth,
Texas) and 1% ephedrine hydrochloride solution, and then
packed with the same pledget to protect the nasal bottom. The
HFL probe was inserted into the nasolacrimal duct until the
packed pledget was moving, a indication that the probe tip was
into the nasal cavity. Then, the electrocauterisation was
performed during the time when the probe pulled back in a
slowly retrograde way. The blocked tissue in the nasolacrimal
duct was easily cauterised by the energy and became a charred
crust tube. The cauterisation was stopped when the probe was
almost out of the nasolacrimal duct. The HFL probe was then
reinserted into the nasolacrimal duct to check any remaining
obstruction. If there was any resistance, the electrocauterisation
procedure was repeated until the HFL probe passed freely and
smoothly through the nasolacrimal duct. The lacrimal drainage
system was then irrigated with antibiotic solution.
Postoperative care
All patients were prescribed topical antibiotic eye-drops and a
nasal mucosa astringent four times a day for 10 days. The
lacrimal passage was irrigated with antibiotic solution weekly in
the first half month after surgery. Postoperative evaluation and
long-term follow-up were performed by the same doctors.
Criteria defining the clinical effects
Clinical success was defined by the results of the dye
disappearance test, lacrimal irrigation and symptoms. ‘‘Full
success’’ was noted if the fluorescent stain was positive in
5 min, indicating the free nasolacrimal passage, and the
symptoms were completely resolved. The lacrimal irrigation
was performed if no fluorescent stain was found, or the stain
was found after more than 10 min. ‘‘Partial success’’ was noted
if the pledget was stained with fluorescein after lacrimal
irrigation and there was no reflux. ‘‘Partial success’’ was also
scored for the patient who had some symptoms but no reflux in
lacrimal irrigation. ‘‘Failure’’ was defined as no improvement or
recurrence in tearing with severe reflux in irrigation at the last
follow-up.
Histopathological study after RC-NLDO in rhesus monkeys
Twelve rhesus monkeys (1.5–2 years old and weighing 4–6 kg)
were purchased from Guangdong Medical Laboratory Animal
Center, Guangdong, China. Experimental procedures were
performed adhering to the ARVO statement for the Use of
Animals in Ophthalmic and Vision Research. One eye randomly
chosen from each monkey was used in RC-NLDO, and the other
eye from each animal was used as an untreated normal control.
The surgery and postoperative care were performed in the same
manner as for the patients described above. The animals were
killed by an overdose of barbiturates 7 days, 1 month, 2 months
and 3 months after surgery. Specimens including canaliculi,
lacrimal sac and nasolacrimal duct were carefully collected for
histopathological examination.
RESULTS
Patient preoperative conditions
The patient preoperative conditions are summarised in table 1.
The duration of symptoms ranged from 6 months to 26 years
Table 1 Preoperative conditions of patients in two groups
Preoperative conditions
Recanalisation of nasolacrimal duct obstruction External dacryocystorhinostomy
n (percentage of total (506)) n (percentage of total (135))
Total 506 (100.0%) 135 (100.0%)
Nasolacrimal duct obstruction 125 (24.80%) 51 (37.78%)
Chronic dacryocystitis 255 (50.40%) 72 (53.33%)
Mucocoele 14 (2.77%) 2 (1.48%)
Fistulae 10 (1.98%) 0 (0%)
Small lacrimal sac 45 (8.80%) 0 (0%)
Atrophic rhinitis 8 (1.58%) 0 (0%)
Failed in external
dacryocystorhinostomy
23 (4.55%) 3 (2.22%)
Failed in silicone intubation 26 (5.14%) 7 (5.19%)
Table 2 Clinical outcome in two groups
Variable
Recanalisation of nasolacrimal
duct obstruction
External
dacryocystorhinostomy
n (%) n (%)
Primary surgery 506 (100.0) 135 (100.0) p*
Full success 440 (86.96) 118 (87.41)
Partial success 31 (6.13) 5 (3.70)
Total success 471 (93.08) 123 (91.11)
Failure 35 (6.92) 12 (8.89)
Second surgery 27 (100.0) 10 (100.0) p{
Full success 20 (74.07) 4 (40.0)
Partial success 3 (11.11) 0 (0)
Total success 23 (85.19) 4 (40.0)
Failure 4 (14.81) 6 (60.0)
*p=0.816, two-sample t test (a=0.05).
**p=0.013, two-sample t test (a=0.05).
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17 years (mean 4.7 years) in the EX-DCR group. There were 49
(9.67%) recurrent cases suffering tearing from previously
unsuccessful surgery (EX-DCR or silicone intubation) in
the RC-NLDO group, and 10 (7.41%) recurrent cases in the
EX-DCR group. The follow-up period after surgeries ranged
from 12 to 54 months (mean 28.5 months).
Clinical effects of the RC-NLDO and EX-DCR treatments
The surgical outcomes are summarised in table 2. The operative
duration for RC-NLDO ranged from 8 to 19 min (12.5 (SD
2.6) min), significantly shorter than the 30–50 min (40.3
(4.7) min) for the EX-DCR group (p,0.001, Student t test).
In the RC-NLDO group, the full success was defined in 440
(86.96%) eyes, partial success in 31 (6.13%) cases and recurrent
in 35 (6.92%) cases. The total success rate reached 93.08% (471/
506) with a single treatment. A total of 27 failed cases
underwent a second repeated surgery 3 months later. After
second surgery, 20 (74.07%) cases achieved full success; three
(11.11%) cases achieved partial success, and only four (14.81%)
cases failed again. The total success rate of second repeated
surgery was 85.19%. In the EX-DCR group, complete success
with symptoms completely resolved was achieved in 118
(87.14%) cases, partial success in five (3.70%) cases and failure
in 12 (8.89%) cases. The total success rate reached 91.11% (123/
135). A total of 10 failed cases underwent repeated surgery, in
which four (40.0%) cases were successful, and six (60.0%) cases
had failed. There was no statistical difference in surgical
outcomes between these two groups for the primary surgery
(p=0.816), while a significant difference was found for the
recurrent patients (p,0.013). The digital subtraction dacryo-
cystogram showed that the reconstructed cavity of the
nasolacrimal duct by RC-NLDO was much wider than normal
(fig 2).
Complications of RC-NLDO and EX-DCR
In the EX-DCR group, one patient (0.74%) suffered post-
operative bleeding immediately after surgery; eight patients
(5.93%) reported transient pain in the upper segment of the
maxillary bone, but it was tolerable; and 30 patients (22.22%)
complained about their visible scars. No infection or uncontrol-
lable bleeding occurred. In the RC-NLDO group, four patients
(0.79%) had postoperative periocular subcutaneous haematoma.
No other complications were observed in this group.
Histopathological results of rhesus monkeys undergoing RC-
NLDO
In normal rhesus monkey, the lacrimal sac is lined by stratified
columnar epithelium containing scattered goblet cells on a
Figure 2 Digital subtraction
dacryocystogram. (A) Completely
obstructed right nasolacrimal duct and a
normal left one before recanalisation of
nasolacrimal duct obstruction (RC-NLDO)
surgery. (B) Free flow of the contrast
medium through the recanalised
nasolacrimal duct to the inferior meatus
3 weeks after RC-NLDO operation.
Figure 1 Lacrimal canaliser (model WZC-III) with accessories. (I) Main
instrument containing an on/off switch (A), an output power control (B)
and a reset button (C) with three cable connectors (1, 2 and 3) for
connections to accessories: a positive electrode cable that links to the
high-frequency lacrimal probe (see part II), negative electrode tongs (D)
and foot pedal (E), respectively. (II) Lacrimal probe images showing: (A)
its 2.0 mm long, naked (without an insulating coat on the surface) and
conducting tip 1.2 mm in diameter; (B) an 80 mm long and 1.2 mm
diameter probe body with a thin layer of non-toxic and insulating coat on
the surface; (C) a 60 mm long and 5 mm diameter head part of the probe
covered by a rubber layer; (D) a special ‘‘buckle’’ structure of the probe
top.
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1440 Br J Ophthalmol 2009;93:1438–1443. doi:10.1136/bjo.2008.149393Figure 3 Representative images showing histomorphological structures of the nasolacrimal duct mucosa in cross-sections of rhesus monkeys before
and after recanalisation of nasolacrimal duct obstruction (RC-NLDO) surgery. (A, B) Normal morphological structure of nasolacrimal duct mucosa in
rhesus monkey; (C, D) nasolacrimal duct mucosa in rhesus monkey immediately after RC-NLDO surgery, showing almost total loss of epithelium in
nasolacrimal duct with a few residual cells on the basal membrane. (E, F) Notable migration of cells from adjacent residual epithelia, 1 week after
surgery. The epithelial cells formed a single layer and loosely covered the surface of the basement membrane. Scattered or focal infiltrations of
inflammatory cells were visible in the lamina propria. (G, H) Completely healed epithelium with two layers of cells similar to the normal controls,
1 month after surgery. There was no visible inflammatory cell infiltration in lamina propria. (I, J) Two months after surgery. (K, L) Three months after
surgery. The epithelia in specimens from 2 to 3 months later became morphologically and histologically normal. Magnification:6200 in images A, C, E,
G, I and K; 6400 in B, D, F, H, J and L.
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by a double layer of epithelium, a superficial layer of columnar
cells and a basal layer of non-keratinised squamous cells
(fig 3A,B). It differs histologically from the lacrimal sac in that
it lacks goblet cells.
The healing process of the epithelium in the nasolacrimal
duct after RC-NLDO surgery in the rhesus monkey was
evaluated by histopathological examinations. Cross-sections of
the specimens obtained immediately after RC-NLDO displayed
the intact epithelium of the lacrimal sac and an almost total loss
of epithelium in the nasolacrimal duct with a few residual cells
appearing as small islands on the basal membrane (fig 3C,D).
Sections of the specimens collected 1 week after surgery showed
notable migration of cells from adjacent residual epithelia. The
epithelial cells formed a single layer and loosely covered the
surface of the basement membrane. Scattered or focal infiltra-
tions of inflammatory cells were visible in the lamina propria
(fig 3E,F). Specimens from 1 month after surgery displayed a
completely healed epithelium with two layers of cells similar to
the normal controls. There was no visible inflammatory cell
infiltration in the lamina propria (fig 3G,H). The epithelia in
specimens from 2 to 3 months later became morphologically
and histologically normal (fig 3I–L). No granulation tissue was
noted in all specimens.
DISCUSSION
The ideal treatment for NLDO is to recanalise the obstructed
duct and restore normal anatomical structure and physiological
function of the lacrimal drainage system. The EX-DCR is a
successful operation with a success rate of 80–95%, but it is a
relatively complex procedure
6 and involves skin incision and
bone removal to create a mucosal fistula from the lacrimal sac
directly into the nasal cavity, which leaves a facial cutaneous
scar and disruption of the medial canthal anatomy.
1561 61 7
In order to overcome these disadvantages, a number of
therapeutic developments and promising advances in DCR have
been reported recently, such as endonasal (endoscopic) DCR
and endocanalicular laser DCR.
91 8However, these new techni-
ques have obvious disadvantages, such as their time-consuming
nature and a marked learning curve.
5–9 In addition, the EX-DCR
and these new approaches do not restore the obstructed
nasolacrimal duct but make a bypass draining system, which
is not a physiological tear passage.
Recanalisation of the nasolacrimal duct obstruction (RC-
NLDO) was a simple and evolutional approach for treating
NLDO and chronic dacryocystitis. In the last 5 years, we have
been conducting this study with up to 54-month long-term
follow-up to evaluate the RC-NLDO approach for comparison
with EX-DCR. Our findings demonstrated that the RC-NLDO
was a highly successful approach with an overall success rate at
93.18% for primary surgery and 85.19% for second repeated
surgery. The pathological study in rhesus monkeys further
confirmed that the surgically wounded epithelium in the
nasolacrimal duct was starting to heal in a week and completely
recovered within 1 month, creating a wide recanalised cavity.
RC-NLDO has achieved a high success rate that was
comparable with EX-DCR. This may be due to the following
factors. First a larger lumen was created (fig 2B). In laser
treatment, the cavity created is narrower due to the limited
diameter (0.4–0.6 mm) of the laser fibre. However, in RC-
NLDO, the diameter of the HFL probe is 1.2 mm. According to
the formula ‘‘S=pr
2,’’ the reopened area (S=1.13 mm
2) of the
duct cavity in cross-section by RC-NLDO was 4–9-fold larger
than the laser-created cavity (0.13–0.28 mm
2). According to the
Poiseuille law, the flow resistance is the fourth power inversely
proportional to the radius of the duct, the tear flow resistance
through the cavity created by RC-NLDO would be 16–81-fold
lower than that created by laser treatment. Second is the lower
incidence of false passage formation. No false passage formation
is essential for success. In normal conditions, the soft tissue of
the membranaceous nasolacrimal duct adheres tightly to its
surrounding osseous nasolacrimal duct. Therefore, when there is
no false passage formation, the direction of surgical scar
contraction is acentric, which pulls the soft tissue to the wall
of the osseous nasolacrimal duct, so the gently acentric
contraction of the surgical scar would not obstruct the cavity
and would not reduce the success rate. If the false passage was
formed, the direction of the surgical scar contract would pull
itself towards the centre of the reconstructed nasolacrimal duct,
which would narrow or block the cavity. The false passage
could be avoided in most cases if the electrocauterisation was
performed simultaneously while slowly withdrawing the HFL
probe after its tip was inserted into the nasal cavity during the
RC-NLDO procedure.
The RC-NLDO technique has several other advantages, such as
(1) minimal trauma and no facial cutaneous scar due to the
surgery being performed without cutaneous incision and bone
excision; (2) less disruption of the lacrimal pump function due to
the surgery restoring a physiological tear passage without making
a bypass draining system; (3) a simpler, easier and faster (average
12.5 min) procedure similar to conventional lacrimal probing.
Usually, the lower canaliculus is ascendant in tear drainage
(about 75%). Thus, the superior canaliculus was chosen for the
HFL probe to pass through, which protected the function of tear
drainage in case of any unexpected damage. The most
obstructed points could be penetrated by rotational manipula-
tion along with a slight force during electrocauterisation. In the
procedure, the obstructed tissue was cauterised to an eschar
crust tube tightly adhering to the wall of the reopened cavity,
and became a transitorily sustaining membrane to the wall of
the reconstructed nasolacrimal duct. Additionally, while the
HFL probe is withdrawn, the rotational manipulation could
keep the eschar crust tube intact and minimise the risk of
postoperative bleeding, inflammation and synechia.
The RC-NLDO is also a choice of treatment for patients who
suffer from a lacrimal sac mucocoele, obstructed lacrimal duct
with atrophic rhinitis or small lacrimal sac. The RC-NLDO is
suitable for patients who failed to respond to a previous EX-DCR.
RC-NLDO is not suitable for treating an obstructed osseous
nasolacrimal duct which could be treated with EX-DCR.
Contraindications for RC-NLDO also include acute dacryocystitis,
suspicion of malignancy and patients suffering from severe
hypertensionorseverecardiacdisease(especiallywithapacemaker).
In conclusion, a simple and evolutional approach RC-NLDO
has been evaluated by long-term follow-up in a large patient
population and animal pathological examination, and the
findings demonstrated that this new approach has been proven
to recanalise the nasolacrimal duct obstructions. When com-
pared with EX-DCR, RC-NLDO is a new option for treating
NLDO and chronic dacryocystitis with a similar or better
clinical success rate. The advantages include its efficacy,
minimal invasion, safety and simplicity. RC-NLDO is also an
optimal choice for recurrent patients who failed to respond to
EX-DCR and for patients with small lacrimal sacs or atrophic
rhinitis who are not suitable for EX-DCR.
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